COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

CMS Releases FAQs for CLIA Certificates and University Laboratories

CMS maze of rules and regulations
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

New clarification provided by CMS for CLIA considerations for university laboratories

The US Centers for Medicare and Medicaid Services (CMS) released guidance for Clinical Laboratory Improvement Amendments (CLIA) requirements and regulatory information for university laboratories. This guidance was issued in the form of a questions and answers document and was made available on Aug. 31, 2020.

The CMS CLIA guidance addressed three questions: 

  1. For a facility’s need for a CLIA certificate when performing SARS-CoV-2 surveillance testing using pooled sampling for non-patient-specific reporting: CMS states, “Facilities performing SARS-CoV-2 surveillance testing using a pooled sampling procedure to report non patient-specific SARS-CoV-2 cohort results will not require CLIA certification.”
  2. On a university notifying a specific person that they should seek testing in a CLIA-certified laboratory: CMS clarifies that “If at any time a patient-specific result is reported, the facility is subject to CLIA and required to obtain an appropriate CLIA certificate.” CMS does, however, offer enforcement discretion for SARS-CoV-2 surveillance testing where patient-specific results are reported, provided that the university laboratory does not provide the test result to the patient and refers them to a CLIA-certified laboratory for further diagnostic testing.
  3. How a university laboratory can obtain CLIA certification: CMS outlines resources and methods by which university laboratories can either operate under an existing CLIA certificate of an affiliated university laboratory, or can apply for a CLIA certificate.

Clinical laboratory leaders can view the full text of the CMS Q&As here.

Related Resource:

CLIA and University Laboratory Testing FAQ

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group